Physician profile
Karen Everett
NPI 1972855161
$980.62
in general payments reported to CMS, 2019-2025
16 companies · $80.81 in 2025
The $80.81 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $410 · 2022: $167 · 2023: $145 · 2024: $178 · 2025: $80.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $316.59 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $131.56 | 2021-2025 | Mounjaro, Trulicity, Zepbound |
| Exact Sciences Corporation | $107.57 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $104.07 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $44.41 | 2021-2023 | Livalo |
| Takeda Pharmaceuticals U.S.A., INC. | $44.17 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.51 | 2021 | |
| Novartis Pharmaceuticals Corporation | $36.11 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $35.05 | 2021 | |
| Pfizer INC. | $22.71 | 2021 | |
| Harmony Biosciences LLC | $22.24 | 2025 | |
| Glaxosmithkline, LLC. | $16.57 | 2022 | |
| Abbott Laboratories | $16.36 | 2022 | |
| Amarin Pharma, INC. | $15.78 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.91 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Everett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.